Belite Bio (BLTE) Stock Chart & Stock Price History $64.58 +1.00 (+1.56%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Belite Bio Stock Price Performance The Belite Bio (BLTE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 32.45%, with a year-to-date return of 2.35%. In the past month, the stock has increased 11.93%, reflecting recent market activity. As of the latest close, Belite Bio traded at $63.59 with a market cap of $1.98 billion and volume of 12,620 shares. Receive BLTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.77%1 Month Performance+11.93%3 Month Performance+5.05%Year-To-Date Performance+2.35%1 Year Performance+32.45% BLTE Stock Chart for Wednesday, July, 30, 2025 BLTE Chart by TradingView Belite Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/29/2025$62.05$63.59+2.48%$63.95$62.0812,620 shs$1.98 billion07/28/2025$62.24$62.05-0.31%$62.38$61.5010,234 shs$1.98 billion07/25/2025$61.85$62.24+0.63%$62.48$61.0220,602 shs$1.98 billion07/24/2025$62.31$61.85-0.74%$62.48$61.0122,622 shs$1.97 billion07/23/2025$59.67$62.31+4.42%$62.37$60.3721,150 shs$1.98 billion07/22/2025$61.30$59.67-2.66%$62.64$59.12132,211 shs$1.90 billion07/21/2025$60.92$61.30+0.62%$62.60$61.2044,334 shs$1.95 billion07/18/2025$60.99$60.92-0.11%$61.55$60.4730,551 shs$1.94 billion07/17/2025$62.05$60.99-1.71%$62.28$60.0832,097 shs$1.94 billion07/16/2025$63.32$62.05-2.01%$63.30$61.4153,096 shs$1.98 billion Get the Latest News and Ratings for BLTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. 07/15/2025$63.58$63.32-0.41%$65.30$63.00172,332 shs$2.02 billion07/14/2025$63.22$63.58+0.57%$64.10$62.25125,270 shs$2.02 billion07/11/2025$62.03$63.22+1.92%$63.62$60.60180,040 shs$2.01 billion07/10/2025$64.16$62.03-3.32%$63.44$61.1839,840 shs$1.98 billion07/09/2025$60.12$64.16+6.72%$64.20$59.0661,930 shs$2.04 billion07/08/2025$58.63$60.12+2.54%$61.20$58.77112,117 shs$1.91 billion07/07/2025$59.74$58.63-1.86%$59.45$57.9960,241 shs$1.87 billion07/04/2025$59.74$59.74$59.65$57.6864,433 shs$1.90 billion07/03/2025$56.81$59.74+5.16%$59.65$57.6864,433 shs$1.90 billion07/02/2025$57.16$56.81-0.61%$59.51$56.10114,550 shs$1.81 billion07/01/2025$57.70$57.16-0.94%$59.71$56.5979,680 shs$1.82 billion06/30/2025$59.04$57.70-2.27%$59.30$57.4655,405 shs$1.84 billion Related Companies ROIV Stock Price Chart RGC Stock Price Chart ELAN Stock Price Chart RVMD Stock Price Chart GRFS Stock Price Chart TGTX Stock Price Chart NUVL Stock Price Chart CRSP Stock Price Chart RYTM Stock Price Chart LNTH Stock Price Chart Receive BLTE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Belite Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BLTE) was last updated on 7/30/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredDrone Company Secures Major Defense Contract Amid Sweeping Policy ShiftOn July 10th, the White House and DoD announced a sweeping new directive to fast-track U.S. drone dominance. ...The Tomorrow Investor | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredOne stock to replace Nvidia"I said 'SELL' before this stock dropped 90%. Today, I'm shouting 'BUY NOW' before it's too late." In 2000,...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
